Human iPSC–Derived Endothelial Cells Exhibit Reduced Immunogenicity in Comparison With Human Primary Endothelial Cells
Human induced pluripotent stem cell (iPSC)–derived endothelial cells (ECs) have emerged as a promising source of autologous cells with great potential to produce novel cell therapy for ischemic vascular diseases. However, their clinical application still faces numerous challenges including safety co...
Saved in:
| Main Authors: | Haiyan Jia, Melanie Moore, Meenu Wadhwa, Chris Burns |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/sci/6153235 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human iPSC-derived myelinating organoids and globoid cells to study Krabbe disease.
by: Lisa Marie P Evans, et al.
Published: (2024-01-01) -
The role of phosphofructokinase P in hypertrophy of iPSC-derived human cardiomyocytes
by: Katarzyna Kmiotek, et al.
Published: (2024-11-01) -
Human iPSC-derived neural stem cells engraft and improve pathophysiology of MPS I mice
by: Caitlin C. Calhoun, et al.
Published: (2024-12-01) -
Transcriptome-wide RNA 5-methylcytosine profiles of human iPSCs and iPSC-derived cardiomyocytes
by: Szu-Ying Chen, et al.
Published: (2024-12-01) -
The Effects of Co-injecting Human iPSC-Derived Cardiomyocytes/Pre-epicardial Cells into Cryoinjured Rat Hearts
by: Fatin Fazrina Roslan, et al.
Published: (2024-07-01)